A cerebrospinal fluid detection test for Alzheimer's disease core biomarkers that provides enhanced sensitivity and more accurate results. This product targets the pathological hallmarks of Alzheimer's disease.
Manufactured by
China
CanAg Diagnostics (Fujirebio) is a global leader in in-vitro diagnostics and the world's largest manufacturer of tumor marker gold standards. The company provides detection products for most common solid tumors including gastrointestinal, squamous cell, liver, pancreatic, prostate, ovarian, skin, and lung cancers. All products are manufactured in ISO13485-certified facilities in Sweden and USA, supplying tumor marker antigens and antibodies to major international diagnostic manufacturers.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Randox Laboratories Ltd.
United Kingdom · 2 relevant products
GenSure Biotech Inc.
China · 1 relevant product
BioChain (Beijing) Science & Technology. Inc.
China · 3 relevant products
53 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →11 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 94 closest product alternatives
Randox Laboratories Ltd. · United Kingdom
Biomarker tests and diagnostic solutions for Alzheimer's disease assessment. These products support early detection and monitoring of neurodegenerative disease.
GenSure Biotech Inc. · China
Diagnostic test kit for measurement of biomarkers associated with cerebrovascular disease and stroke risk. Facilitates assessment of neurological and cerebrovascular health status.
BioChain (Beijing) Science & Technology. Inc. · China
Diagnostic test for early detection of cognitive impairment and neurodegenerative disease risk. This biomarker-based test supports early intervention strategies for age-related cognitive disorders. The product aligns with research collaborations in epigenetic disease markers.
91 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products